nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Confusional state—Paclitaxel—breast cancer	0.000514	0.000562	CcSEcCtD
Flumazenil—Erythema—Capecitabine—breast cancer	0.000512	0.000561	CcSEcCtD
Flumazenil—Pruritus—Thiotepa—breast cancer	0.000512	0.00056	CcSEcCtD
Flumazenil—Pain—Fluorouracil—breast cancer	0.000511	0.00056	CcSEcCtD
Flumazenil—Nausea—Goserelin—breast cancer	0.000502	0.00055	CcSEcCtD
Flumazenil—Feeling abnormal—Gemcitabine—breast cancer	0.000501	0.000549	CcSEcCtD
Flumazenil—Dizziness—Vinorelbine—breast cancer	0.000501	0.000548	CcSEcCtD
Flumazenil—Tachycardia—Paclitaxel—breast cancer	0.000497	0.000544	CcSEcCtD
Flumazenil—Urticaria—Mitoxantrone—breast cancer	0.000496	0.000543	CcSEcCtD
Flumazenil—Feeling abnormal—Fluorouracil—breast cancer	0.000493	0.00054	CcSEcCtD
Flumazenil—Hyperhidrosis—Paclitaxel—breast cancer	0.000492	0.000539	CcSEcCtD
Flumazenil—Drowsiness—Methotrexate—breast cancer	0.000488	0.000534	CcSEcCtD
Flumazenil—Vision blurred—Capecitabine—breast cancer	0.000483	0.000528	CcSEcCtD
Flumazenil—Vomiting—Vinorelbine—breast cancer	0.000481	0.000527	CcSEcCtD
Flumazenil—Tremor—Capecitabine—breast cancer	0.00048	0.000525	CcSEcCtD
Flumazenil—Dizziness—Thiotepa—breast cancer	0.000478	0.000524	CcSEcCtD
Flumazenil—Rash—Vinorelbine—breast cancer	0.000477	0.000523	CcSEcCtD
Flumazenil—Dermatitis—Vinorelbine—breast cancer	0.000477	0.000522	CcSEcCtD
Flumazenil—Hypotension—Paclitaxel—breast cancer	0.000476	0.000521	CcSEcCtD
Flumazenil—Ill-defined disorder—Capecitabine—breast cancer	0.000475	0.00052	CcSEcCtD
Flumazenil—Urticaria—Fluorouracil—breast cancer	0.000475	0.00052	CcSEcCtD
Flumazenil—Headache—Vinorelbine—breast cancer	0.000474	0.000519	CcSEcCtD
Flumazenil—Sweating—Methotrexate—breast cancer	0.000468	0.000512	CcSEcCtD
Flumazenil—Palpitations—Docetaxel—breast cancer	0.000467	0.000512	CcSEcCtD
Flumazenil—Malaise—Capecitabine—breast cancer	0.000462	0.000506	CcSEcCtD
Flumazenil—Cough—Docetaxel—breast cancer	0.000462	0.000505	CcSEcCtD
Flumazenil—Insomnia—Paclitaxel—breast cancer	0.000461	0.000504	CcSEcCtD
Flumazenil—Vertigo—Capecitabine—breast cancer	0.00046	0.000504	CcSEcCtD
Flumazenil—Hypersensitivity—Mitoxantrone—breast cancer	0.00046	0.000504	CcSEcCtD
Flumazenil—Hypersensitivity—Irinotecan—breast cancer	0.00046	0.000504	CcSEcCtD
Flumazenil—Vomiting—Thiotepa—breast cancer	0.00046	0.000503	CcSEcCtD
Flumazenil—Paraesthesia—Paclitaxel—breast cancer	0.000457	0.000501	CcSEcCtD
Flumazenil—Hypertension—Docetaxel—breast cancer	0.000457	0.0005	CcSEcCtD
Flumazenil—Drowsiness—Epirubicin—breast cancer	0.000457	0.0005	CcSEcCtD
Flumazenil—Rash—Thiotepa—breast cancer	0.000456	0.000499	CcSEcCtD
Flumazenil—Dermatitis—Thiotepa—breast cancer	0.000456	0.000499	CcSEcCtD
Flumazenil—Dyspnoea—Paclitaxel—breast cancer	0.000454	0.000497	CcSEcCtD
Flumazenil—Headache—Thiotepa—breast cancer	0.000453	0.000496	CcSEcCtD
Flumazenil—Somnolence—Paclitaxel—breast cancer	0.000453	0.000496	CcSEcCtD
Flumazenil—Palpitations—Capecitabine—breast cancer	0.000453	0.000495	CcSEcCtD
Flumazenil—Chest pain—Docetaxel—breast cancer	0.00045	0.000493	CcSEcCtD
Flumazenil—Nausea—Vinorelbine—breast cancer	0.00045	0.000492	CcSEcCtD
Flumazenil—Asthenia—Irinotecan—breast cancer	0.000448	0.000491	CcSEcCtD
Flumazenil—Asthenia—Mitoxantrone—breast cancer	0.000448	0.000491	CcSEcCtD
Flumazenil—Cough—Capecitabine—breast cancer	0.000447	0.000489	CcSEcCtD
Flumazenil—Hypertension—Capecitabine—breast cancer	0.000442	0.000484	CcSEcCtD
Flumazenil—Hypersensitivity—Fluorouracil—breast cancer	0.000441	0.000482	CcSEcCtD
Flumazenil—Dry mouth—Docetaxel—breast cancer	0.00044	0.000482	CcSEcCtD
Flumazenil—Fatigue—Paclitaxel—breast cancer	0.000439	0.000481	CcSEcCtD
Flumazenil—Sweating—Epirubicin—breast cancer	0.000438	0.000479	CcSEcCtD
Flumazenil—Asthenia—Gemcitabine—breast cancer	0.000436	0.000478	CcSEcCtD
Flumazenil—Chest pain—Capecitabine—breast cancer	0.000436	0.000477	CcSEcCtD
Flumazenil—Pain—Paclitaxel—breast cancer	0.000436	0.000477	CcSEcCtD
Flumazenil—Confusional state—Docetaxel—breast cancer	0.000435	0.000477	CcSEcCtD
Flumazenil—Anxiety—Capecitabine—breast cancer	0.000434	0.000476	CcSEcCtD
Flumazenil—Discomfort—Capecitabine—breast cancer	0.000431	0.000472	CcSEcCtD
Flumazenil—Pruritus—Gemcitabine—breast cancer	0.00043	0.000471	CcSEcCtD
Flumazenil—Nausea—Thiotepa—breast cancer	0.00043	0.00047	CcSEcCtD
Flumazenil—Dry mouth—Capecitabine—breast cancer	0.000426	0.000467	CcSEcCtD
Flumazenil—Pruritus—Fluorouracil—breast cancer	0.000423	0.000463	CcSEcCtD
Flumazenil—Drowsiness—Doxorubicin—breast cancer	0.000422	0.000462	CcSEcCtD
Flumazenil—Visual impairment—Methotrexate—breast cancer	0.000422	0.000462	CcSEcCtD
Flumazenil—Confusional state—Capecitabine—breast cancer	0.000421	0.000461	CcSEcCtD
Flumazenil—Tachycardia—Docetaxel—breast cancer	0.000421	0.000461	CcSEcCtD
Flumazenil—Feeling abnormal—Paclitaxel—breast cancer	0.00042	0.000459	CcSEcCtD
Flumazenil—Bradycardia—Epirubicin—breast cancer	0.000417	0.000457	CcSEcCtD
Flumazenil—Dizziness—Irinotecan—breast cancer	0.000413	0.000452	CcSEcCtD
Flumazenil—Tinnitus—Methotrexate—breast cancer	0.000408	0.000447	CcSEcCtD
Flumazenil—Tachycardia—Capecitabine—breast cancer	0.000408	0.000447	CcSEcCtD
Flumazenil—Hypoaesthesia—Epirubicin—breast cancer	0.000408	0.000446	CcSEcCtD
Flumazenil—Sweating—Doxorubicin—breast cancer	0.000405	0.000443	CcSEcCtD
Flumazenil—Urticaria—Paclitaxel—breast cancer	0.000405	0.000443	CcSEcCtD
Flumazenil—Hyperhidrosis—Capecitabine—breast cancer	0.000404	0.000442	CcSEcCtD
Flumazenil—Hypotension—Docetaxel—breast cancer	0.000403	0.000442	CcSEcCtD
Flumazenil—Vomiting—Irinotecan—breast cancer	0.000397	0.000435	CcSEcCtD
Flumazenil—Vomiting—Mitoxantrone—breast cancer	0.000397	0.000435	CcSEcCtD
Flumazenil—Dizziness—Fluorouracil—breast cancer	0.000396	0.000433	CcSEcCtD
Flumazenil—Visual impairment—Epirubicin—breast cancer	0.000395	0.000432	CcSEcCtD
Flumazenil—Rash—Irinotecan—breast cancer	0.000394	0.000431	CcSEcCtD
Flumazenil—Rash—Mitoxantrone—breast cancer	0.000394	0.000431	CcSEcCtD
Flumazenil—Dermatitis—Mitoxantrone—breast cancer	0.000393	0.000431	CcSEcCtD
Flumazenil—Dermatitis—Irinotecan—breast cancer	0.000393	0.000431	CcSEcCtD
Flumazenil—Chills—Methotrexate—breast cancer	0.000393	0.00043	CcSEcCtD
Flumazenil—Headache—Irinotecan—breast cancer	0.000391	0.000428	CcSEcCtD
Flumazenil—Headache—Mitoxantrone—breast cancer	0.000391	0.000428	CcSEcCtD
Flumazenil—Hypotension—Capecitabine—breast cancer	0.000391	0.000428	CcSEcCtD
Flumazenil—Insomnia—Docetaxel—breast cancer	0.00039	0.000427	CcSEcCtD
Flumazenil—Paraesthesia—Docetaxel—breast cancer	0.000388	0.000424	CcSEcCtD
Flumazenil—Vomiting—Gemcitabine—breast cancer	0.000387	0.000423	CcSEcCtD
Flumazenil—Bradycardia—Doxorubicin—breast cancer	0.000386	0.000423	CcSEcCtD
Flumazenil—Dyspnoea—Docetaxel—breast cancer	0.000385	0.000421	CcSEcCtD
Flumazenil—Somnolence—Docetaxel—breast cancer	0.000384	0.00042	CcSEcCtD
Flumazenil—Rash—Gemcitabine—breast cancer	0.000384	0.00042	CcSEcCtD
Flumazenil—Dermatitis—Gemcitabine—breast cancer	0.000383	0.00042	CcSEcCtD
Flumazenil—Tinnitus—Epirubicin—breast cancer	0.000382	0.000418	CcSEcCtD
Flumazenil—Erythema—Methotrexate—breast cancer	0.000381	0.000417	CcSEcCtD
Flumazenil—Headache—Gemcitabine—breast cancer	0.000381	0.000417	CcSEcCtD
Flumazenil—Flushing—Epirubicin—breast cancer	0.00038	0.000416	CcSEcCtD
Flumazenil—Vomiting—Fluorouracil—breast cancer	0.00038	0.000416	CcSEcCtD
Flumazenil—Insomnia—Capecitabine—breast cancer	0.000378	0.000414	CcSEcCtD
Flumazenil—Hypoaesthesia—Doxorubicin—breast cancer	0.000377	0.000413	CcSEcCtD
Flumazenil—Rash—Fluorouracil—breast cancer	0.000377	0.000413	CcSEcCtD
Flumazenil—Dermatitis—Fluorouracil—breast cancer	0.000377	0.000412	CcSEcCtD
Flumazenil—Paraesthesia—Capecitabine—breast cancer	0.000375	0.000411	CcSEcCtD
Flumazenil—Hypersensitivity—Paclitaxel—breast cancer	0.000375	0.000411	CcSEcCtD
Flumazenil—Headache—Fluorouracil—breast cancer	0.000375	0.00041	CcSEcCtD
Flumazenil—Dyspnoea—Capecitabine—breast cancer	0.000373	0.000408	CcSEcCtD
Flumazenil—Fatigue—Docetaxel—breast cancer	0.000372	0.000407	CcSEcCtD
Flumazenil—Nausea—Mitoxantrone—breast cancer	0.000371	0.000406	CcSEcCtD
Flumazenil—Nausea—Irinotecan—breast cancer	0.000371	0.000406	CcSEcCtD
Flumazenil—Pain—Docetaxel—breast cancer	0.000369	0.000404	CcSEcCtD
Flumazenil—Chills—Epirubicin—breast cancer	0.000368	0.000403	CcSEcCtD
Flumazenil—Arrhythmia—Epirubicin—breast cancer	0.000366	0.000401	CcSEcCtD
Flumazenil—Visual impairment—Doxorubicin—breast cancer	0.000365	0.0004	CcSEcCtD
Flumazenil—Asthenia—Paclitaxel—breast cancer	0.000365	0.0004	CcSEcCtD
Flumazenil—Nausea—Gemcitabine—breast cancer	0.000361	0.000396	CcSEcCtD
Flumazenil—Fatigue—Capecitabine—breast cancer	0.00036	0.000395	CcSEcCtD
Flumazenil—Pruritus—Paclitaxel—breast cancer	0.00036	0.000394	CcSEcCtD
Flumazenil—Vision blurred—Methotrexate—breast cancer	0.000359	0.000393	CcSEcCtD
Flumazenil—Pain—Capecitabine—breast cancer	0.000357	0.000391	CcSEcCtD
Flumazenil—Erythema—Epirubicin—breast cancer	0.000357	0.000391	CcSEcCtD
Flumazenil—Feeling abnormal—Docetaxel—breast cancer	0.000356	0.000389	CcSEcCtD
Flumazenil—Nausea—Fluorouracil—breast cancer	0.000355	0.000389	CcSEcCtD
Flumazenil—Ill-defined disorder—Methotrexate—breast cancer	0.000354	0.000387	CcSEcCtD
Flumazenil—Tinnitus—Doxorubicin—breast cancer	0.000354	0.000387	CcSEcCtD
Flumazenil—Flushing—Doxorubicin—breast cancer	0.000352	0.000385	CcSEcCtD
Flumazenil—Tension—Epirubicin—breast cancer	0.00035	0.000383	CcSEcCtD
Flumazenil—Nervousness—Epirubicin—breast cancer	0.000347	0.000379	CcSEcCtD
Flumazenil—Feeling abnormal—Capecitabine—breast cancer	0.000344	0.000377	CcSEcCtD
Flumazenil—Malaise—Methotrexate—breast cancer	0.000344	0.000376	CcSEcCtD
Flumazenil—Vertigo—Methotrexate—breast cancer	0.000343	0.000375	CcSEcCtD
Flumazenil—Chills—Doxorubicin—breast cancer	0.00034	0.000373	CcSEcCtD
Flumazenil—Arrhythmia—Doxorubicin—breast cancer	0.000339	0.000371	CcSEcCtD
Flumazenil—Dizziness—Paclitaxel—breast cancer	0.000337	0.000369	CcSEcCtD
Flumazenil—Vision blurred—Epirubicin—breast cancer	0.000336	0.000368	CcSEcCtD
Flumazenil—Cough—Methotrexate—breast cancer	0.000333	0.000364	CcSEcCtD
Flumazenil—Urticaria—Capecitabine—breast cancer	0.000332	0.000364	CcSEcCtD
Flumazenil—Ill-defined disorder—Epirubicin—breast cancer	0.000331	0.000362	CcSEcCtD
Flumazenil—Erythema—Doxorubicin—breast cancer	0.00033	0.000361	CcSEcCtD
Flumazenil—Agitation—Epirubicin—breast cancer	0.000328	0.000359	CcSEcCtD
Flumazenil—Chest pain—Methotrexate—breast cancer	0.000325	0.000355	CcSEcCtD
Flumazenil—Tension—Doxorubicin—breast cancer	0.000324	0.000355	CcSEcCtD
Flumazenil—Vomiting—Paclitaxel—breast cancer	0.000324	0.000355	CcSEcCtD
Flumazenil—Malaise—Epirubicin—breast cancer	0.000322	0.000352	CcSEcCtD
Flumazenil—Rash—Paclitaxel—breast cancer	0.000321	0.000352	CcSEcCtD
Flumazenil—Dermatitis—Paclitaxel—breast cancer	0.000321	0.000351	CcSEcCtD
Flumazenil—Discomfort—Methotrexate—breast cancer	0.000321	0.000351	CcSEcCtD
Flumazenil—Nervousness—Doxorubicin—breast cancer	0.000321	0.000351	CcSEcCtD
Flumazenil—Vertigo—Epirubicin—breast cancer	0.000321	0.000351	CcSEcCtD
Flumazenil—Headache—Paclitaxel—breast cancer	0.000319	0.000349	CcSEcCtD
Flumazenil—Hypersensitivity—Docetaxel—breast cancer	0.000318	0.000348	CcSEcCtD
Flumazenil—Palpitations—Epirubicin—breast cancer	0.000315	0.000345	CcSEcCtD
Flumazenil—Confusional state—Methotrexate—breast cancer	0.000314	0.000343	CcSEcCtD
Flumazenil—Cough—Epirubicin—breast cancer	0.000311	0.000341	CcSEcCtD
Flumazenil—Vision blurred—Doxorubicin—breast cancer	0.000311	0.000341	CcSEcCtD
Flumazenil—Asthenia—Docetaxel—breast cancer	0.00031	0.000339	CcSEcCtD
Flumazenil—Hypertension—Epirubicin—breast cancer	0.000308	0.000337	CcSEcCtD
Flumazenil—Hypersensitivity—Capecitabine—breast cancer	0.000308	0.000337	CcSEcCtD
Flumazenil—Ill-defined disorder—Doxorubicin—breast cancer	0.000306	0.000335	CcSEcCtD
Flumazenil—Pruritus—Docetaxel—breast cancer	0.000305	0.000334	CcSEcCtD
Flumazenil—Chest pain—Epirubicin—breast cancer	0.000304	0.000333	CcSEcCtD
Flumazenil—Agitation—Doxorubicin—breast cancer	0.000303	0.000332	CcSEcCtD
Flumazenil—Anxiety—Epirubicin—breast cancer	0.000303	0.000331	CcSEcCtD
Flumazenil—Nausea—Paclitaxel—breast cancer	0.000303	0.000331	CcSEcCtD
Flumazenil—Hyperhidrosis—Methotrexate—breast cancer	0.000301	0.000329	CcSEcCtD
Flumazenil—Discomfort—Epirubicin—breast cancer	0.0003	0.000329	CcSEcCtD
Flumazenil—Asthenia—Capecitabine—breast cancer	0.0003	0.000328	CcSEcCtD
Flumazenil—Malaise—Doxorubicin—breast cancer	0.000298	0.000326	CcSEcCtD
Flumazenil—Dry mouth—Epirubicin—breast cancer	0.000297	0.000325	CcSEcCtD
Flumazenil—Vertigo—Doxorubicin—breast cancer	0.000297	0.000325	CcSEcCtD
Flumazenil—Pruritus—Capecitabine—breast cancer	0.000296	0.000324	CcSEcCtD
Flumazenil—Confusional state—Epirubicin—breast cancer	0.000294	0.000321	CcSEcCtD
Flumazenil—Palpitations—Doxorubicin—breast cancer	0.000292	0.000319	CcSEcCtD
Flumazenil—Hypotension—Methotrexate—breast cancer	0.000291	0.000318	CcSEcCtD
Flumazenil—Cough—Doxorubicin—breast cancer	0.000288	0.000315	CcSEcCtD
Flumazenil—Dizziness—Docetaxel—breast cancer	0.000285	0.000313	CcSEcCtD
Flumazenil—Hypertension—Doxorubicin—breast cancer	0.000285	0.000312	CcSEcCtD
Flumazenil—Tachycardia—Epirubicin—breast cancer	0.000284	0.000311	CcSEcCtD
Flumazenil—Hyperhidrosis—Epirubicin—breast cancer	0.000281	0.000308	CcSEcCtD
Flumazenil—Insomnia—Methotrexate—breast cancer	0.000281	0.000308	CcSEcCtD
Flumazenil—Chest pain—Doxorubicin—breast cancer	0.000281	0.000308	CcSEcCtD
Flumazenil—Anxiety—Doxorubicin—breast cancer	0.00028	0.000307	CcSEcCtD
Flumazenil—Paraesthesia—Methotrexate—breast cancer	0.000279	0.000306	CcSEcCtD
Flumazenil—Discomfort—Doxorubicin—breast cancer	0.000278	0.000304	CcSEcCtD
Flumazenil—Dyspnoea—Methotrexate—breast cancer	0.000277	0.000304	CcSEcCtD
Flumazenil—Somnolence—Methotrexate—breast cancer	0.000277	0.000303	CcSEcCtD
Flumazenil—Dizziness—Capecitabine—breast cancer	0.000276	0.000303	CcSEcCtD
Flumazenil—Dry mouth—Doxorubicin—breast cancer	0.000275	0.000301	CcSEcCtD
Flumazenil—Vomiting—Docetaxel—breast cancer	0.000274	0.0003	CcSEcCtD
Flumazenil—Rash—Docetaxel—breast cancer	0.000272	0.000298	CcSEcCtD
Flumazenil—Hypotension—Epirubicin—breast cancer	0.000272	0.000298	CcSEcCtD
Flumazenil—Dermatitis—Docetaxel—breast cancer	0.000272	0.000298	CcSEcCtD
Flumazenil—Confusional state—Doxorubicin—breast cancer	0.000272	0.000297	CcSEcCtD
Flumazenil—Headache—Docetaxel—breast cancer	0.00027	0.000296	CcSEcCtD
Flumazenil—Fatigue—Methotrexate—breast cancer	0.000268	0.000294	CcSEcCtD
Flumazenil—Pain—Methotrexate—breast cancer	0.000266	0.000291	CcSEcCtD
Flumazenil—Vomiting—Capecitabine—breast cancer	0.000266	0.000291	CcSEcCtD
Flumazenil—Rash—Capecitabine—breast cancer	0.000264	0.000289	CcSEcCtD
Flumazenil—Insomnia—Epirubicin—breast cancer	0.000263	0.000288	CcSEcCtD
Flumazenil—Dermatitis—Capecitabine—breast cancer	0.000263	0.000288	CcSEcCtD
Flumazenil—Tachycardia—Doxorubicin—breast cancer	0.000263	0.000288	CcSEcCtD
Flumazenil—Headache—Capecitabine—breast cancer	0.000262	0.000287	CcSEcCtD
Flumazenil—Paraesthesia—Epirubicin—breast cancer	0.000261	0.000286	CcSEcCtD
Flumazenil—Hyperhidrosis—Doxorubicin—breast cancer	0.00026	0.000285	CcSEcCtD
Flumazenil—Dyspnoea—Epirubicin—breast cancer	0.00026	0.000284	CcSEcCtD
Flumazenil—Somnolence—Epirubicin—breast cancer	0.000259	0.000283	CcSEcCtD
Flumazenil—Nausea—Docetaxel—breast cancer	0.000256	0.000281	CcSEcCtD
Flumazenil—Feeling abnormal—Methotrexate—breast cancer	0.000256	0.000281	CcSEcCtD
Flumazenil—Hypotension—Doxorubicin—breast cancer	0.000252	0.000276	CcSEcCtD
Flumazenil—Fatigue—Epirubicin—breast cancer	0.000251	0.000275	CcSEcCtD
Flumazenil—Pain—Epirubicin—breast cancer	0.000249	0.000273	CcSEcCtD
Flumazenil—Nausea—Capecitabine—breast cancer	0.000248	0.000272	CcSEcCtD
Flumazenil—Urticaria—Methotrexate—breast cancer	0.000247	0.000271	CcSEcCtD
Flumazenil—Insomnia—Doxorubicin—breast cancer	0.000244	0.000267	CcSEcCtD
Flumazenil—Paraesthesia—Doxorubicin—breast cancer	0.000242	0.000265	CcSEcCtD
Flumazenil—Dyspnoea—Doxorubicin—breast cancer	0.00024	0.000263	CcSEcCtD
Flumazenil—Feeling abnormal—Epirubicin—breast cancer	0.00024	0.000263	CcSEcCtD
Flumazenil—Somnolence—Doxorubicin—breast cancer	0.00024	0.000262	CcSEcCtD
Flumazenil—Fatigue—Doxorubicin—breast cancer	0.000232	0.000254	CcSEcCtD
Flumazenil—Urticaria—Epirubicin—breast cancer	0.000231	0.000253	CcSEcCtD
Flumazenil—Pain—Doxorubicin—breast cancer	0.00023	0.000252	CcSEcCtD
Flumazenil—Hypersensitivity—Methotrexate—breast cancer	0.000229	0.000251	CcSEcCtD
Flumazenil—Asthenia—Methotrexate—breast cancer	0.000223	0.000244	CcSEcCtD
Flumazenil—Feeling abnormal—Doxorubicin—breast cancer	0.000222	0.000243	CcSEcCtD
Flumazenil—Pruritus—Methotrexate—breast cancer	0.00022	0.000241	CcSEcCtD
Flumazenil—Hypersensitivity—Epirubicin—breast cancer	0.000215	0.000235	CcSEcCtD
Flumazenil—Urticaria—Doxorubicin—breast cancer	0.000214	0.000234	CcSEcCtD
Flumazenil—Asthenia—Epirubicin—breast cancer	0.000209	0.000229	CcSEcCtD
Flumazenil—Pruritus—Epirubicin—breast cancer	0.000206	0.000226	CcSEcCtD
Flumazenil—Dizziness—Methotrexate—breast cancer	0.000206	0.000225	CcSEcCtD
Flumazenil—Hypersensitivity—Doxorubicin—breast cancer	0.000198	0.000217	CcSEcCtD
Flumazenil—Vomiting—Methotrexate—breast cancer	0.000198	0.000217	CcSEcCtD
Flumazenil—Rash—Methotrexate—breast cancer	0.000196	0.000215	CcSEcCtD
Flumazenil—Dermatitis—Methotrexate—breast cancer	0.000196	0.000215	CcSEcCtD
Flumazenil—Headache—Methotrexate—breast cancer	0.000195	0.000213	CcSEcCtD
Flumazenil—Asthenia—Doxorubicin—breast cancer	0.000193	0.000212	CcSEcCtD
Flumazenil—Dizziness—Epirubicin—breast cancer	0.000193	0.000211	CcSEcCtD
Flumazenil—Pruritus—Doxorubicin—breast cancer	0.000191	0.000209	CcSEcCtD
Flumazenil—Vomiting—Epirubicin—breast cancer	0.000185	0.000203	CcSEcCtD
Flumazenil—Nausea—Methotrexate—breast cancer	0.000185	0.000202	CcSEcCtD
Flumazenil—Rash—Epirubicin—breast cancer	0.000184	0.000201	CcSEcCtD
Flumazenil—Dermatitis—Epirubicin—breast cancer	0.000183	0.000201	CcSEcCtD
Flumazenil—Headache—Epirubicin—breast cancer	0.000182	0.0002	CcSEcCtD
Flumazenil—Dizziness—Doxorubicin—breast cancer	0.000178	0.000195	CcSEcCtD
Flumazenil—Nausea—Epirubicin—breast cancer	0.000173	0.000189	CcSEcCtD
Flumazenil—Vomiting—Doxorubicin—breast cancer	0.000171	0.000188	CcSEcCtD
Flumazenil—Rash—Doxorubicin—breast cancer	0.00017	0.000186	CcSEcCtD
Flumazenil—Dermatitis—Doxorubicin—breast cancer	0.00017	0.000186	CcSEcCtD
Flumazenil—Headache—Doxorubicin—breast cancer	0.000169	0.000185	CcSEcCtD
Flumazenil—Nausea—Doxorubicin—breast cancer	0.00016	0.000175	CcSEcCtD
Flumazenil—GABRA1—Neuronal System—ACHE—breast cancer	0.000149	0.00172	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—BCHE—breast cancer	0.000149	0.00172	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000148	0.00171	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000145	0.00167	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—NFKBIA—breast cancer	0.000144	0.00166	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—COMT—breast cancer	0.000144	0.00166	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000143	0.00165	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000143	0.00165	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000143	0.00165	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—COMT—breast cancer	0.000142	0.00164	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000142	0.00164	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000141	0.00163	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.00014	0.00161	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—APC—breast cancer	0.000139	0.00161	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000139	0.00161	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000137	0.00159	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—COMT—breast cancer	0.000135	0.00156	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000135	0.00156	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000134	0.00155	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000133	0.00154	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000133	0.00154	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—FOS—breast cancer	0.000133	0.00153	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000132	0.00152	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000132	0.00152	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000131	0.00152	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000131	0.00151	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—BCHE—breast cancer	0.00013	0.0015	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—HIF1A—breast cancer	0.000127	0.00147	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—COMT—breast cancer	0.000126	0.00146	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000126	0.00145	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—COMT—breast cancer	0.000124	0.00143	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000123	0.00142	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—COMT—breast cancer	0.000122	0.00141	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000122	0.0014	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000121	0.0014	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—COMT—breast cancer	0.000121	0.0014	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—TUBB3—breast cancer	0.00012	0.00139	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—BRAF—breast cancer	0.00012	0.00138	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000119	0.00138	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—COMT—breast cancer	0.000119	0.00137	CbGpPWpGaD
Flumazenil—GABRA6—Ion channel transport—RAF1—breast cancer	0.000118	0.00137	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—BRAF—breast cancer	0.000118	0.00137	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000118	0.00137	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000118	0.00136	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000117	0.00135	CbGpPWpGaD
Flumazenil—GABRA4—Ion channel transport—RAF1—breast cancer	0.000117	0.00135	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000117	0.00135	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000117	0.00135	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000115	0.00133	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000115	0.00133	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000115	0.00133	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000115	0.00132	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000113	0.00131	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000113	0.0013	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000112	0.0013	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000112	0.00129	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.00011	0.00127	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.00011	0.00127	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—RAF1—breast cancer	0.000109	0.00126	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—RELA—breast cancer	0.000109	0.00126	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MTOR—breast cancer	0.000107	0.00123	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—BRAF—breast cancer	0.000105	0.00121	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000104	0.00121	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—TFRC—breast cancer	0.000104	0.0012	CbGpPWpGaD
Flumazenil—GABRA5—Ion channel transport—RAF1—breast cancer	0.000104	0.0012	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—COMT—breast cancer	0.000104	0.0012	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000103	0.00119	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—BRAF—breast cancer	0.000103	0.00119	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—TFRC—breast cancer	0.000103	0.00119	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000103	0.00118	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000102	0.00118	CbGpPWpGaD
Flumazenil—GABRA3—Ion channel transport—RAF1—breast cancer	0.000102	0.00118	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—BRAF—breast cancer	0.000101	0.00117	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000101	0.00116	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—BRAF—breast cancer	0.000101	0.00116	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000101	0.00116	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—MDM2—breast cancer	0.0001	0.00116	CbGpPWpGaD
Flumazenil—GABRA2—Ion channel transport—RAF1—breast cancer	0.0001	0.00116	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.0001	0.00116	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—NCOA2—breast cancer	0.0001	0.00116	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—RAF1—breast cancer	0.0001	0.00115	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—RAF1—breast cancer	9.96e-05	0.00115	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—MDM2—breast cancer	9.91e-05	0.00114	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—BRAF—breast cancer	9.89e-05	0.00114	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—NCOA2—breast cancer	9.88e-05	0.00114	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCG2—breast cancer	9.88e-05	0.00114	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—RAF1—breast cancer	9.87e-05	0.00114	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC2A2—breast cancer	9.84e-05	0.00114	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CASP3—breast cancer	9.82e-05	0.00113	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCG2—breast cancer	9.81e-05	0.00113	CbGpPWpGaD
Flumazenil—GABRG2—Ion channel transport—RAF1—breast cancer	9.78e-05	0.00113	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCG2—breast cancer	9.64e-05	0.00111	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	9.64e-05	0.00111	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	9.6e-05	0.00111	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC5A5—breast cancer	9.55e-05	0.0011	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—JUN—breast cancer	9.54e-05	0.0011	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CTNNB1—breast cancer	9.47e-05	0.00109	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC5A5—breast cancer	9.43e-05	0.00109	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.22e-05	0.00107	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—BRAF—breast cancer	9.18e-05	0.00106	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—TFRC—breast cancer	9.12e-05	0.00105	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.11e-05	0.00105	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—BRAF—breast cancer	9.06e-05	0.00105	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MAPK8—breast cancer	9.03e-05	0.00104	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—TFRC—breast cancer	8.96e-05	0.00103	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—TFRC—breast cancer	8.8e-05	0.00102	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—MDM2—breast cancer	8.8e-05	0.00102	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—NCOA2—breast cancer	8.78e-05	0.00101	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—RAF1—breast cancer	8.77e-05	0.00101	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—TFRC—breast cancer	8.75e-05	0.00101	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—BRAF—breast cancer	8.65e-05	0.000999	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—MDM2—breast cancer	8.65e-05	0.000998	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—NCOA2—breast cancer	8.62e-05	0.000996	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—RAF1—breast cancer	8.62e-05	0.000995	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC2A2—breast cancer	8.6e-05	0.000993	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—TFRC—breast cancer	8.59e-05	0.000992	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—SRC—breast cancer	8.56e-05	0.000988	CbGpPWpGaD
Flumazenil—GABRA1—Ion channel transport—RAF1—breast cancer	8.55e-05	0.000987	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—MDM2—breast cancer	8.5e-05	0.000981	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—NCOA2—breast cancer	8.48e-05	0.000979	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—RAF1—breast cancer	8.47e-05	0.000978	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—MDM2—breast cancer	8.44e-05	0.000975	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—NCOA1—breast cancer	8.44e-05	0.000974	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCG2—breast cancer	8.42e-05	0.000973	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—NCOA2—breast cancer	8.42e-05	0.000972	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—RAF1—breast cancer	8.41e-05	0.000971	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC5A5—breast cancer	8.38e-05	0.000968	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—NCOA1—breast cancer	8.33e-05	0.000962	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—MDM2—breast cancer	8.29e-05	0.000957	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—NCOA2—breast cancer	8.27e-05	0.000955	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CXCL8—breast cancer	8.26e-05	0.000954	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—RAF1—breast cancer	8.26e-05	0.000954	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—STAT3—breast cancer	8.25e-05	0.000953	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC5A5—breast cancer	8.23e-05	0.00095	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—PLG—breast cancer	8.22e-05	0.000949	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—PLG—breast cancer	8.12e-05	0.000937	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC2A1—breast cancer	8.09e-05	0.000935	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC5A5—breast cancer	8.09e-05	0.000934	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—BRAF—breast cancer	8.05e-05	0.00093	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC5A5—breast cancer	8.03e-05	0.000928	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.95e-05	0.000918	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL1B—breast cancer	7.93e-05	0.000915	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CASP3—breast cancer	7.91e-05	0.000913	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—BRAF—breast cancer	7.91e-05	0.000913	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC5A5—breast cancer	7.89e-05	0.000911	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MAPK3—breast cancer	7.89e-05	0.000911	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.81e-05	0.000902	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—BRAF—breast cancer	7.77e-05	0.000897	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.76e-05	0.000896	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—BRAF—breast cancer	7.72e-05	0.000891	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—MDM2—breast cancer	7.69e-05	0.000888	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—JUN—breast cancer	7.68e-05	0.000887	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—RAF1—breast cancer	7.66e-05	0.000885	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	7.62e-05	0.00088	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.62e-05	0.00088	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—MDM2—breast cancer	7.59e-05	0.000877	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—HMOX1—breast cancer	7.59e-05	0.000876	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—BRAF—breast cancer	7.58e-05	0.000875	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—RAF1—breast cancer	7.57e-05	0.000874	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—TFRC—breast cancer	7.51e-05	0.000867	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—HMOX1—breast cancer	7.49e-05	0.000865	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—NCOA1—breast cancer	7.4e-05	0.000855	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	7.32e-05	0.000846	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCB1—breast cancer	7.28e-05	0.000841	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—NCOA1—breast cancer	7.27e-05	0.000839	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—MDM2—breast cancer	7.24e-05	0.000837	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	7.23e-05	0.000835	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—NCOA2—breast cancer	7.23e-05	0.000835	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—RAF1—breast cancer	7.22e-05	0.000834	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—PLG—breast cancer	7.21e-05	0.000833	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCB1—breast cancer	7.19e-05	0.00083	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—NCOA1—breast cancer	7.14e-05	0.000825	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—NCOA1—breast cancer	7.1e-05	0.000819	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—PLG—breast cancer	7.08e-05	0.000818	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—NCOA1—breast cancer	6.97e-05	0.000805	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—PLG—breast cancer	6.96e-05	0.000804	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—PLG—breast cancer	6.91e-05	0.000799	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.89e-05	0.000796	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—PLG—breast cancer	6.79e-05	0.000784	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—MDM2—breast cancer	6.75e-05	0.000779	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—RAF1—breast cancer	6.72e-05	0.000776	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—VEGFA—breast cancer	6.71e-05	0.000775	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.66e-05	0.000769	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—HMOX1—breast cancer	6.66e-05	0.000769	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—BRAF—breast cancer	6.63e-05	0.000765	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—MDM2—breast cancer	6.62e-05	0.000765	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—RAF1—breast cancer	6.6e-05	0.000762	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—HMOX1—breast cancer	6.54e-05	0.000755	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—MDM2—breast cancer	6.51e-05	0.000752	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—RAF1—breast cancer	6.49e-05	0.000749	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—MDM2—breast cancer	6.47e-05	0.000747	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—RAF1—breast cancer	6.44e-05	0.000744	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	6.43e-05	0.000742	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—HMOX1—breast cancer	6.42e-05	0.000742	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCB1—breast cancer	6.39e-05	0.000738	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—HMOX1—breast cancer	6.38e-05	0.000737	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—MDM2—breast cancer	6.35e-05	0.000733	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—RAF1—breast cancer	6.33e-05	0.000731	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	6.31e-05	0.000729	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCB1—breast cancer	6.27e-05	0.000725	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—HMOX1—breast cancer	6.27e-05	0.000724	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	6.2e-05	0.000716	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCB1—breast cancer	6.17e-05	0.000712	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	6.16e-05	0.000712	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCB1—breast cancer	6.12e-05	0.000707	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—NCOA1—breast cancer	6.09e-05	0.000703	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	6.05e-05	0.000699	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—HRAS—breast cancer	6.02e-05	0.000696	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCB1—breast cancer	6.01e-05	0.000695	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—PLG—breast cancer	5.93e-05	0.000685	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—TNF—breast cancer	5.75e-05	0.000664	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—MDM2—breast cancer	5.55e-05	0.000641	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—RAF1—breast cancer	5.53e-05	0.000639	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—HRAS—breast cancer	5.51e-05	0.000636	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—HMOX1—breast cancer	5.48e-05	0.000633	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—HRAS—breast cancer	5.44e-05	0.000628	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—AKT1—breast cancer	5.32e-05	0.000614	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	5.29e-05	0.000611	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCB1—breast cancer	5.26e-05	0.000607	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—HRAS—breast cancer	4.83e-05	0.000558	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—HRAS—breast cancer	4.74e-05	0.000548	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—HRAS—breast cancer	4.66e-05	0.000538	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL6—breast cancer	4.64e-05	0.000536	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—HRAS—breast cancer	4.63e-05	0.000535	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ALB—breast cancer	4.56e-05	0.000526	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—HRAS—breast cancer	4.55e-05	0.000525	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ALB—breast cancer	4.5e-05	0.000519	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—HRAS—breast cancer	4.22e-05	0.000487	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—HRAS—breast cancer	4.17e-05	0.000481	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—RAF1—breast cancer	4.12e-05	0.000476	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—RAF1—breast cancer	4.07e-05	0.00047	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ALB—breast cancer	4e-05	0.000462	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—HRAS—breast cancer	3.98e-05	0.000459	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ALB—breast cancer	3.92e-05	0.000453	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ALB—breast cancer	3.86e-05	0.000445	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ALB—breast cancer	3.83e-05	0.000443	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ALB—breast cancer	3.76e-05	0.000435	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—HRAS—breast cancer	3.7e-05	0.000427	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—HRAS—breast cancer	3.63e-05	0.00042	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—RAF1—breast cancer	3.61e-05	0.000417	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—HRAS—breast cancer	3.57e-05	0.000413	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—RAF1—breast cancer	3.55e-05	0.00041	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—HRAS—breast cancer	3.55e-05	0.00041	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—RAF1—breast cancer	3.49e-05	0.000403	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—HRAS—breast cancer	3.48e-05	0.000402	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—RAF1—breast cancer	3.47e-05	0.0004	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—RAF1—breast cancer	3.4e-05	0.000393	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ALB—breast cancer	3.29e-05	0.00038	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—HRAS—breast cancer	3.05e-05	0.000352	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—RAF1—breast cancer	2.97e-05	0.000343	CbGpPWpGaD
